切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2015, Vol. 12 ›› Issue (09) : 667 -680. doi: 10.3877/cma.j.issn.1672-6448.2015.09.002

所属专题: 总编推荐 文献 指南共识

专家共识

中国心血管超声造影增强检查专家共识
中华医学会超声医学分会超声心动图学组   
  • 收稿日期:2015-08-01 出版日期:2015-09-01
  • Received:2015-08-01 Published:2015-09-01
引用本文:

中华医学会超声医学分会超声心动图学组. 中国心血管超声造影增强检查专家共识[J]. 中华医学超声杂志(电子版), 2015, 12(09): 667-680.

表1 超声造影增强技术
图1 多巴酚丁胺负荷心肌造影超声心动图流程图
图2 急性心肌梗死后使用心肌造影超声心动图流程图
图3 近期心肌梗死后使用心肌造影超声心动图流程图
[1]
Waggoner AD, Ehler D, Adams D, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: recommendations of the American Society of Echocardiography Council on Cardiac Sonography[J]. J Am Soc Echocardiogr, 2001, 14(5):417–420.
[2]
Mulvagh SL, Rakowski H, Vannan MA, et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography[J]. J Am Soc Echocardiogr, 2008, 21(11):1179–1201.
[3]
McCulloch ML, Mulvagh SL, Olson JJ, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography[J]. J Am Soc Echocardiogr, 2014, 27(8):797–810.
[4]
Senior R, Becher H, Monaghan M, et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography[J]. Eur J Echocardiogr, 2009, 10(2):194–212.
[5]
Simpson DH, Chin CT, Burns PN. Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents[J]. IEEE Trans Ultrason Ferroelectr Freq Control, 1999, 46(2):372–382.
[6]
Meltzer RS. Food and Drug Administration ultrasound device regulation: the output display standard, the "mechanical index" and ultrasound safety[J]. J Am Soc Echocardiogr, 1996, 9(2):216–220.
[7]
Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms[J]. Circulation, 1995, 92(9):2391–2395.
[8]
Tiemann K, Lohmeier S, Kuntz S, et al. Real-time contrast echo assessment of myocardial perfusion at low emission power: first experimental and clinical results using power pulse inversion imaging[J]. Echocardiography, 1999, 16(8):799–809.
[9]
刘延玲, 刘汉英, 李建荣, 等. 右心声学造影诊断房间隔缺损230例报告[J]. 中国循环杂志, 1986, 1(2):105.
[10]
高云华, 左松, 朱贤胜, 等. 手振微气泡在右心声学造影中的应用研究[J]. 中国超声医学杂志, 2001, 17(12):894–896.
[11]
Soliman OII, Geleijnse ML, Meijboom FJ, et al. The use of contrast echocardiography for the detection of cardiac shunts[J]. Eur J Echocardiography, 2007, 8(3):S2–S12.
[12]
Kirkpatrick JN, Wong T, Bednarz JE, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging[J]. J Am Coll Cardiol, 2004, 43(8):1412–1419.
[13]
Kimura BJ, Phan JN, Housman LB. Utility of contrast echocardiography in the diagnosis of aortic dissection[J]. J Am Soc Echocardiogr, 1999, 12(2):155–159.
[14]
Nakatani S, Imanishi T, Terasawa A, et al. Clinical application of transpulmonary contrast-enhanced Doppler technique in the assessment of severity of aortic stenosis[J]. J Am Coll Cardiol, 1992, 20(4):973–978.
[15]
Crouse LJ, Cheirif J, Hanly DE, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the phase Ⅲ Albunex multicenter trial[J]. J Am Coll Cardiol, 1993, 22(5):1494–1500.
[16]
Kitzman DW, Goldman ME, Gillam LD, et al. Efficacy and safety of the novel ultrasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images[J]. Am J Cardiol, 2000, 86(6):669–674.
[17]
声诺维临床研究协作组. 声诺维在心内膜缘显像及心肌灌注中的效果评价[J]. 中华内科杂志, 2004, 43(11):824–827.
[18]
Rainbird AJ, Mulvagh SL, Oh JK, et al. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients[J]. J Am Soc Echocardiogr, 2001, 14(5):378–385.
[19]
Plana JC, Mikati IA, Dokainish H, et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease: The OPTIMIZE Trial[J]. JACC Cardiovasc Imaging, 2008, 1(2):145–152.
[20]
Vlassak I, Rubin DN, Odabashian JA, et al. Contrast and harmonic imaging improves accuracy and efficiency of novice readers for dobutamine stress echocardiography[J]. Echocardiography, 2002, 19(6):483–488.
[21]
Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study[J]. J Am Coll Cardiol, 2001, 38(3):867–875.
[22]
Yu EH, Sloggett CE, Iwanochko RM, et al. Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients[J]. J Am Soc Echocardiogr, 2000, 13(3):216–224.
[23]
Hoffman R, von Bardelebren S, ten Cate F, et al. Comparison of two- and three-dimensional unenhanced and contrast-enhanced echocardiography versus cineventriculography versus cardiac magnetic resonance for determination of left ventricular function[J]. Am J Cardiol, 2014, 113(2):395–400.
[24]
Jung PH, Mueller M, Schuhmann C, et al. Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events[J]. Cardiovascular Ultrasound, 2013, 11(1):1–5.
[25]
Thanigaraj S, Perez JE. Apical hypertrophic cardiomyopathy: echocardiographic diagnosis with the use of intravenous contrast image enhancement[J]. J Am Soc Echocardiogr, 2000, 13(2):146–149.
[26]
Chow CM, Lim KD, Wu L, et al. Images in cardiovascular medicine: isolated left ventricular noncompaction enhanced by echocontrast agent[J]. Circulation, 2007, 116(4):e90–e91.
[27]
Abdelmoneim SS, Mankad SV, Bernier M, et al. Microvascular function in takotsubo cardiomyopathy with contrast echocardiography: prospective evaluation and review of literature[J]. J Am Soc Echocardiogr, 2009, 22(11):1249–1255.
[28]
朱烨, 陈明. 心腔内超声造影对左心室心肌致密化不全肌小梁的定量分析[J]. 中国医学影像学杂志, 2014, 22(6):405–408.
[29]
Thanigaraj S, Schechtman KB, Perez JE. Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement[J]. J Am Soc Echocardiogr, 1999, 12(12):1022–1026.
[30]
Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast enhanced tissue characterization for detection of left ventricular thrombus[J]. JACC Cardiovasc Imaging, 2009, 8(8):969–979.
[31]
查道刚, 谢志斌, 杨莉, 等. 声学造影评估心内占位性病变血流灌注状况的初步探讨[J]. 临床超声医学杂志, 2006, 8(10):633–635.
[32]
Thanigaraj S, Pérez JE. Diagnosis of cardiac rupture with the use of contrast-enhanced echocardiography[J]. J Am Soc Echocardiogr, 2000, 13(9):862–865.
[33]
Abdelmoneim SS, Moir S, Ammash NM, et al. Contrast microbubbles for assessment of left atrial appendage morphology and function during pre-cardioversion transesophageal echocardiography: useful or not?[J]. Eur J Echocardiogr, 2006, 7(suppl):S189.
[34]
Lepper W, Shivalkar B, Rinkevich D, et al. Assessment of the vascularity of a left ventricular mass using myocardial contrast echocardiography[J]. J Am Soc Echocardiogr, 2002, 15(11):1419–1422.
[35]
Abdelmoneim SS, Bernier M, Dhoble A, et al. Assessment of the vascularity of a left atrial mass using myocardial perfusion contrast echocardiography[J]. Echocardiography, 2008, 25(5):517–520.
[36]
Goldman JH, Foster E. Transesophageal echocardiographic (TEE) evaluationof intracardiac and pericardial masses[J]. Cardiol Clin, 2000, 18(4):849–860.
[37]
Gopal AS, Stathopoulos JA, Arora N, et al. Differential diagnosis of intracavitary tumors obstructing the right ventricular outflow tract[J]. J Am Soc Echocardiogr, 2001, 14(9):937–940.
[38]
Pellikka PA, Roger VL, Oh JK, et al. Stress echocardiography. Part Ⅱ. Dobutamine stress echocardiography: techniques,implementation, clinical applications, and correlations[J]. Mayo Clin Proc, 1995,70(1):16–27.
[39]
Roger VL, Pellikka PA, Oh JK, et al. Stress echocardiography. PartⅠ. Exercise echocardiography: techniques, implementation, clinical applications, and correlations[J]. Mayo Clin Proc ,1995,70(1):5–15.
[40]
Severi S, Picano E, Michelassi C, et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease: comparison with exercise electrocardiography[J]. Circulation, 1994, 89(3):1160–1173.
[41]
郭士遵, 舒先红, 潘翠珍, 等. 心肌超声造影结合多巴酚丁胺试验探讨冠心病心肌灌注与心肌收缩功能的关系[J]. 中华超声影像学杂志, 2005, 14(7):485–489.
[42]
王伟, 穆玉明, 王春梅, 等. 腺苷负荷心肌超声造影评价冠状动脉狭窄程度的研究[J]. 中华超声影像学杂志, 2010, 19(10):846–849.
[43]
McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients[J]. J Am Coll Cardiol, 1998, 31(1):144–149.
[44]
Chuah SC, Pellikka PA, Roger VL, et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease[J]. Circulation, 1998, 97(15):1474–1480.
[45]
Timperley J, Mitchell AR, Thibault H, et al. Safety of contrast dobutamine stress echocardiography: a single center experience[J]. J Am Soc Echocardiogr, 2005, 18(2):163–167.
[46]
Tsutsui JM, Elhendy A, Xie F, et al. Safety of dobutamine stress real-time myocardial contrast echocardiography[J]. J Am Coll Cardiol, 2005, 19(8):1235–1242.
[47]
Aggeli C, Giannopoulos G, Roussakis G, et al. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for detection of ischemiain 5 250 studies[J]. Heart, 2008, 94(12):1571–1577.
[48]
Gaibazzi N, Reverberi C, Lorenzoni V, et al. Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography[J]. Circulation, 2012, 126(10):1217–1224.
[49]
Krenning BJ, Nemes A, Soliman OII, et al. Contrast enhanced three-dimensional dobutamine stress echocardiography: between Scylla and Charybdis?[J]. Eur J Echocardiography, 2008, 9(6):757–760.
[50]
智光, 许勇, 谭国娟, 等. 应用对比脉冲系列成像技术以SonoVue进行心肌造影的初步临床观察[J]. 中国超声医学杂志, 2005, 21(11):833–835.
[51]
吴迪, 姚克纯, 李利, 等. 应用心肌声学造影评价冠状动脉血运重建术心肌灌注[J]. 中国超声医学杂志, 2013, 29(4):338–341.
[52]
Abdelmoneim SS, Bernier M, Scott CG, et al. Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study[J]. Circ Cardiovasc Imaging, 2010, 3(3):240–248.
[53]
Senior R, Monaghan M, Main ML, et al. Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two phase 3 international trials in comparison with radionuclide perfusion imaging[J]. Eur J Echocardiogr, 2009, 10(1):26–35.
[54]
Tsutsui JM, Elhendy A, Anderson JR, et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography[J]. Circulation, 2005, 112(10):1444–1450.
[55]
Kaul S, Senior R, Firschke C, et al. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study[J]. Am Heart J, 2004, 148(1):129–136.
[56]
Jeetley P, Burden L, Greaves K, et al. Prognostic value of myocardial contrast echocardiography in patients presenting to hospital with acute chest pain and negative troponin[J]. Am J Cardiol, 2007, 99(10):1369–1373.
[57]
Janardhanan R, Moon JC, Pennell DJ, et al. Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction[J]. Am Heart J, 2005, 149(2):355–362.
[58]
Galiuto L, Garramone B, Scara` A, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study[J]. J Am Coll Cardiol, 2008, 51(5):552.
[59]
Hickman M, Burden L, Senior R. Resting myocardial blood flow not myocardial blood flow reserve predicts hibernating myocardium: A quantitative myocardial contrast echocardiography study[J]. J Am Coll Cardiol, 2007, 49:131A.
[60]
Hayat SA, Senior R. Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?[J]. Eur Heart J, 2008, 29(3):299–314.
[61]
Feinstein SB. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization[J]. J Am Coll Cardiol, 2006,48(2):236–243.
[62]
Shah F, Balan P, Weinberg M, et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis?[J]. Vasc Med, 2007, 12(4):291–297.
[63]
Grewe PH, Mugge A, Germing A, et al. Occlusion of pseudoaneurysms using human or bovine thrombin using contrast-enhanced ultrasound guidance[J]. Am J Cardiol, 2004, 93(12):1540–1542.
[64]
Staub D, Partini S, Imfeld S, et al. Novel applications of contrast ultrasound imaging in vascular medicine[J]. Vasc, 2013, 42(1):17–31.
[65]
Rinkevich D, Kaul S, Wang XQ, et al. Regional left ventricular perfusion and function in patients presenting to the emergency department with chest pain and no ST-segment elevation[J]. Eur Heart J, 2005, 26(16):1606–1611.
[66]
Tong KL, Kaul S, Wang XQ, et al. Myocardial contrast echocardiography versus thrombolysis in myocardial infarction score in patients presenting to the emergency department with chest pain and a nondiagnostic electrocardiogram[J]. J Am Coll Cardiol, 2005, 46(5):920–927.
[67]
Lee TH, Rouan GW, Weisberg MC, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room[J]. Am J Cardiol, 1987, 60(4):219–224.
[68]
Reilly JP, Tunick PA, Timmermans RJ, et al. Contrast echocardiography clarifies uninterpretable wall motion inintensive care unit patients[J]. J Am Coll Cardiol, 2000, 35(2):485–490.
[69]
Daniel GK, Chawla MK, Sawada SG, et al. Echocardiographic imaging of technically difficult patients in the intensive care unit: use of Optison in combination with fundamental and harmonic imaging[J]. J Am Soc Echocardiogr, 2001, 14(9):917–920.
[70]
Yong Y, Wu D, Fernandes V, et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit[J]. Am J Cardiol, 2002, 89(6):711–718.
[71]
Nagueh SF, Lakkis NM, He ZX, et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy[J]. J Am Coll Cardiol, 1998, 32(1):225–229.
[72]
Faber L, Ziemssen P, Seggewiss H. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring[J]. J Am Soc Echocardiogr, 2000, 13(12):1074–1079.
[73]
Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast chocardiography[J]. Circulation, 1998, 98(22):2415–2421.
[74]
Zilberman MV, Witt SA, Kimball TR. Is there a role for intravenous transpulmonary contrast imaging in pediatric stress echocardiography?[J]. J Am Soc Echocardiogr, 2003, 16(1):9–14.
[75]
McMahon CJ, Ayres NA, Bezold LI, et al. Safety and efficacy of intravenous contrast imaging in pediatric echocardiography[J]. Pediatr Cardiol, 2005, 26(4):413–417.
[76]
苏莉, 尹立雪, 王志刚. 心肌超声造影安全性的研究进展[J]. 中华超声影像学杂志, 2011, 20(6):537–539.
[77]
Kusnetzky LL, Khalid A, Khumri TM, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies[J]. J Am Coll Cardiol, 2008, 51(17):1704–1706.
[78]
Main ML, Ryan AC, Davis TE, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients)[J]. Am J Cardiol, 2008, 102(12):1742–1746.
[79]
Heinle SK, Noblin J, Goree-Best P, et al. Assessment of myocardial perfusion by harmonic power Doppler imaging at rest and during adenosine stress: comparison with 99m Tc-sestamibi SPECT imaging[J]. Circulation, 2000, 102(1):55–60.
[80]
Raisinghani A, Wei KS, Crouse L, et al. Myocardial contrast echocardiography(MCE) with triggered ultrasound does not cause premature ventricular complexes: evidence from PB127 MCE studies[J]. J Am Soc Echocardiogr, 2003, 16(10):1037–1042.
[81]
Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of SonoVue in abdominal applications: retrospective analysis of 23 188 investigations[J]. Ultrasound Med Biol, 2006, 32(9):1369–1375.
[82]
Main ML, Hibberd MG, Ryan A, et al. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent[J]. JACC Cardiovasc Imaging, 2014, 7(1):40–48.
[83]
Dolan MS, Gala SS, Dodla S, et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography: a multicenter experience[J]. J Am Coll Cardiol, 2009, 53(1):32–38.
[84]
Wei K, Main ML, Lang RL, et al. The effect of Definity on systemic and pulmonary hemodynamics in patients[J]. J Am Soc Echocardiogr, 2012, 25(5):584–588.
[85]
Wever-Pinzon O, Suma V, Ahuja A, et al. Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study[J]. Eur Heart J Cardiovasc Imaging, 2012, 13(10):857–862.
[86]
Feinstein SB, Cheirif J, ten Cate FJ, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results[J]. J Am Coll Cardiol, 1990, 16(2):316–324.
No related articles found!
阅读次数
全文


摘要